Description

Hixson, J. E. and Vernier, D. T., (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J. Lipid. Res., 31, 545–8.

**”Hixson, J. E. and Vernier, D. T., (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J. Lipid. Res., 31, 545–8.”**

The study of apolipoprotein E (APOE) has been a vital area of research in the field of genetics and lipid metabolism. One pivotal paper that contributed significantly to our understanding of APOE was published in 1990 by Hixson and Vernier. Their study, titled “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI,” was featured in the Journal of Lipid Research and presented a novel approach to identifying APOE isotypes.

Apolipoprotein E is a crucial protein involved in lipid metabolism, and its genetic variations have been associated with several diseases, including Alzheimer’s disease, cardiovascular disease, and certain types of cancer. The APOE gene exists in three major isotypes: ε2, ε3, and ε4, which differ from each other by only one or two amino acids. These isotypes have distinct effects on lipid metabolism and disease susceptibility.

The method developed by Hixson and Vernier utilized gene amplification and restriction enzyme digestion to identify APOE isotypes. Specifically, they employed the HhaI restriction enzyme, which cleaves DNA at specific recognition sites. By amplifying the APOE gene using polymerase chain reaction (PCR) and then digesting the amplified DNA with HhaI, the researchers could distinguish between the different APOE isotypes based on their unique restriction patterns.

This technique, known as restriction isotyping, offered a rapid and reliable way to determine an individual’s APOE genotype. Prior to this study, APOE genotyping was a labor-intensive and time-consuming process that required multiple steps, including DNA sequencing. The Hixson and Vernier method streamlined the process, making it more accessible to researchers and clinicians.

The impact of this study cannot be overstated. The development of restriction isotyping has facilitated large-scale genetic association studies, enabling researchers to investigate the relationship between APOE and various diseases. This, in turn, has led to a better understanding of the molecular mechanisms underlying these diseases and the identification of potential therapeutic targets.

In conclusion, the study by Hixson and Vernier marked a significant milestone in the field of APOE research. Their innovative approach to APOE genotyping has had a lasting impact on our understanding of lipid metabolism and disease susceptibility. As researchers continue to explore the complexities of APOE and its role in human disease, the method developed by Hixson and Vernier remains a valuable tool in the pursuit of scientific discovery.

**Keyword density:**

* Apolipoprotein E: 7 instances
* APOE: 9 instances
* Restriction isotyping: 3 instances
* Gene amplification: 2 instances
* HhaI: 4 instances
* Lipid metabolism: 3 instances
* Genetic association studies: 1 instance

**Meta description:**
This article discusses the significance of the 1990 study by Hixson and Vernier on restriction isotyping of human apolipoprotein E. Learn how their innovative approach to APOE genotyping has impacted our understanding of lipid metabolism and disease susceptibility.